CrushSCI.com
128.6Average days
123.5Median days
74Fastest days
258Longest days
4482025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

74 days

Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States

Authors
Aaron Nagiel; Stephen R. Russell; Byron L. Lam; Jason I. Comander; Tomas S. Aleman; Cagri G. Besirli; Robert A. Sisk; Paul Yang; Christina Y. Weng; Daniel C. Chung; Aishwarya Thakre; Juha-Matti Savola; David L. RoussoShow moreShow less
Affiliations
Department of Surgery, Vision Center – Ophthalmology, Children’s Hospital Los Angeles, Los Angeles, California; Department of Ophthalmology, Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California; Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida; Inherited Retinal Disorders Service, Massachusetts Eye and Ear, Boston, Massachusetts; Department of Ophthalmology, Scheie Eye Institute and The Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; University of Michigan Health System, Ann Arbor, Michigan; Cincinnati Eye Institute, Blue Ash, Ohio; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon; Baylor College of Medicine, Ophthalmology-Cullen Eye Institute, Houston, Texas; Beacon Therapeutics, Cambridge, Massachusetts; Spark Therapeutics, Inc, Philadelphia, PennsylvaniaShow moreShow less
Source PDF DOI Publisher page
208 days

Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation and Loss in Eyes with Geographic Atrophy

Authors
Justis P. Ehlers; Hasan Cetin; Reem Amine; Karen Matar; Asmita Indurkar; John Mamone; Lyndsey Della Vecchia; Amy Tang; Jamie Reese; Don Luo; Dina Joy K. Abulon; Katherine E. TalcottShow moreShow less
Affiliations
The Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio; Astellas Pharma Inc, Northbrook, IllinoisShow moreShow less
Source PDF DOI Publisher page
258 days

Glaucoma in the UK Biobank

Authors
William Schierding; Aldric Khoo; Emma Akeroyd; Adam S. Butterworth; John Danesh; Helen V. Danesh-MeyerShow moreShow less
Affiliations
Department of Ophthalmology, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand; Vision Research Foundation, Auckland, New Zealand; British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, United Kingdom; British Heart Foundation Centre of Research Excellence, School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, United Kingdom; Health Data Research UK, Wellcome Genome Campus and University of Cambridge, Hinxton, United Kingdom; NIHR Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, United Kingdom; Department of Human Genetics, Wellcome Sanger Institute, Hinxton, United KingdomShow moreShow less
Source PDF DOI Publisher page
76 days

The Effects of a Digital Mindfulness Intervention on Mental Health and Vision-Related Quality of Life in Noninfectious Uveitis

Authors
Jessica G. Shantha; Isabel Ray; Anika Kumar; Daisy Yan; Kirsten Da Silva; Charlene Choo; Alison B. Coyne; Emily Tang; John A. Gonzales; Thuy Doan; Benjamin F. Arnold; Thomas Lietman; Nisha R. AcharyaShow moreShow less
Affiliations
Emory University, Department of Ophthalmology, Atlanta, Georgia; F.I. Proctor Foundation, University of California San Francisco, San Francisco, California; Department of Ophthalmology, University of California San Francisco, San Francisco, California; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CaliforniaShow moreShow less
Source PDF DOI Publisher page
138 days

Polygenic Risk Impacts Lifetime Risk and Prognosis of Glaucoma

Authors
Eemeli S. Tusa; Max Tamlander; Samuli Ripatti; Mika Harju; Karita Salo; Joni A. Turunen; Nina MarsShow moreShow less
Affiliations
Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland; Massachusetts General Hospital, Boston, Massachusetts; Department of Public Health, University of Helsinki, Helsinki, Finland; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Eye Genetics Group, Folkhälsan Research Center, Helsinki, FinlandShow moreShow less
Source PDF DOI Publisher page
120 days

Large Language Model Authorship in Ophthalmic Publications

Authors
Christopher R. Fortenbach; Yue S. Wu; Parth M. Mungra; Russell N. Van GelderShow moreShow less
Affiliations
Department of Ophthalmology, University of Washington School of Medicine, Seattle, Washington; Karalis-Johnson Retina Center, Department of Ophthalmology, University of Washington School of Medicine, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington; Department of Neurobiology & Biophysics, University of Washington, Seattle, WashingtonShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does OPHTHALMOLOGY take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for OPHTHALMOLOGY. The fastest paper went from submission to acceptance in 74 days (Interim Results from a Multicenter Observational Safety Study of Patients Treated with Voretigene Neparvovec-Rzyl in the United States, received 2026-04-27, accepted 2026-07-10); the slowest took 258 days. The average is 128.6 days and the median is 123.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.